Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

This study has been completed.
Department of Health and Human Services
Information provided by (Responsible Party):
Cellerant Therapeutics Identifier:
First received: February 11, 2011
Last updated: June 29, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 10, 2016